Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-24
2008-11-04
Wilson, James O. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C544S098000, C544S298000, C544S383000, C546S001000, C548S356100, C548S400000
Reexamination Certificate
active
07446210
ABSTRACT:
The present invention is directed to novel compounds of Formula I:and forms and pharmaceutical compositions thereof, and the use thereof as inhibitors of Factor Xa.
REFERENCES:
patent: 5444038 (1995-08-01), James et al.
patent: 7067507 (2006-06-01), Pulley et al.
patent: 2003/0114448 (2003-06-01), Zhang et al.
patent: WO 95/29189 (1995-11-01), None
patent: WO 99/33800 (1999-07-01), None
patent: WO 00/01389 (2000-01-01), None
patent: WO 02/051831 (2002-04-01), None
patent: WO 02/48159 (2002-06-01), None
patent: WO 03/044014 (2003-05-01), None
patent: WO 2004/002405 (2004-01-01), None
patent: WO 2004/002477 (2004-01-01), None
patent: WO 2004/050636 (2004-06-01), None
patent: WO 2004/056815 (2004-07-01), None
patent: WO 2004/058743 (2004-07-01), None
McQueen, M. Clinica Chimica Acta, 2002, 315 (1-2), 5-15.
Chi et al. Expert Opinion on Investigational Drugs, 1997, 6(11), 1591-1605).
PCT International Search Report, PCT/US05/38182, May 23, 2006.
H. Theo Cuypers, et al.,Sulfhydryl Content of Bovine Eye Lens Leucine Aminopeptidase: Determination of The Reactivity of The Sulfhydryl Groups of The Zinc Metalloenzyme, of The Enzyme Activated by Mg2+, Mn2+, and Co2+, and of The Metal-Free Apoenzyme, Journal of Biological Chemistry, vol. 257, No. 12, 1982, pp. 7086-7091.
Alan J. Barrett,Proteinase Inhibitors: Potential Drugs,?Biochemistry Department, Strangeways Laboratory, Cambridge CB1, 4RN, UK), pp. 219-229, 1980.
Carlo Tapparelli, et al.,Synthetic Low-molecular Weight Thrombin Inhibitors: Molecular Design and Pharmacological Profile, TiPS, Oct. 1992, vol. 14, pp. 366-376.
J. Lefkovits, et al.,Direct Thrombin Inhibitors in Cardiovascular Medicine, Journal AHA, 1994; 90, pp. 1522-1536.
L. A. Harker,Strategies for Inhibiting The Effects of Thrombin, Blood Coagulation and Fibrinolysis, vol. 5, Suppl 1, 1994, pp. S47-S58.
Shaun R. Coughlin,Molecular Mechanisms of Thrombin Signaling, Seminars in Hematology, vol. 31, No. 4, 1994, pp. 270-277.
Goran Claeson,Synthetic Peptides and Peptidomimetics as Substrates and Inhibitors of Thrombin and Other Proteases in The Blood Coagulation System, Blood Coagulation and Fibrinolysis, vol. 5, 1994, pp. 411-436.
Susan Elodi, et al.,Optimization of Conditions for The Catalytic Effect of The Factor Ixa—Factor VIII Complex: Probable Role of The Complex in The Amplification of Blood Coagulation, Thrombosis Research15; Pergamon Press Ltd. 1979, pp. 617-629.
Lee Yu-Kai
Lu Tianbao
Markotan Thomas P.
Milkiewicz Karen L.
Pan Wenxi
Donnelly Laura
Janssen Pharmaceutica N.V.
Jarrell Noble
Wilson James O.
LandOfFree
Factor Xa compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Factor Xa compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Factor Xa compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4039773